Dr James Lunney MP

Health Canada C. difficile Further Concerns Promising Solutions Regulatory Failure Policy ActionOTTAWA, On: Further to information released on April 9 and April 30, today's focus is on further concerns and promising solutions. The Drug Safety & Effectiveness Network (DSEN) report of 2012 confirms concerns about the strong association between common stomach medications and C. difficile infections (CDI). 'If the regulator cannot or will not act in the public interest then it falls to policy makers to advance the public interest and adjust the mandate of the regulator.' Today, I wish to draw attention to research that further links these medications with increased risk .[click here for full story]May 14. 2014Hospital Infections, Drugs, Deaths What is Wrong with Health Canada?OTTAWA, On: In 2005, I was assured by the Health Minister of the day that Health Canada was actively investigating C. difficile deaths in Canadian hospitals and the relation to stomach acid suppressant drugs called Proton Pump Inhibitors (PPIs).